Girelli, Domenico

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics

Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals

Cited by 1,866

Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis

Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 860

Immunoassay for human serum hepcidin

Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 688

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

Do, R., Stitziel, N. O., Won, H.-H., Jørgensen, A. B., Duga, S., Angelica Merlini, P., Kiezun, A., Farrall, M., Goel, A., Zuk, O., et al. (2015) · Nature

Lipoproteins and Cardiovascular HealthGenetic Associations and Epidemiology

Cited by 650

Differential regulation of iron homeostasis during human macrophage polarized activation

Recalcati, S., Locati, M., Marini, A., Santambrogio, P., Zaninotto, F., De Pizzol, M., Zammataro, L., Girelli, D., & Cairo, G. (2010) · European Journal of Immunology

Iron Metabolism and DisordersImmune cells in cancer

Cited by 438

Hepcidin in the diagnosis of iron disorders

Girelli, D., Nemeth, E., & Swinkels, D. W. (2016) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 417

Heterogeneity of hemochromatosis in Italy

Piperno, A., Sampietro, M., Pietrangelo, A., Arosio, C., Lupica, L., Montosi, G., Vergani, A., Fraquelli, M., Girelli, D., & Pasquero, P. (1998) · Gastroenterology

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 235

Prevalence of Body Iron Excess in the Metabolic Syndrome

Bozzini, C., Girelli, D., Olivieri, O., Martinelli, N., Bassi, A., De Matteis, G., Tenuti, I., Lotto, V., Friso, S., Pizzolo, F., et al. (2005) · Diabetes Care

Iron Metabolism and DisordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 224

Molecular basis for the recently described hereditary hyperferritinemia- cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation") [see comments]

Girelli, D., Corrocher, R., Bisceglia, L., Olivieri, O., De Franceschi, L., Zelante, L., & Gasparini, P. (1995) · Blood

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 196

Reduced serum hepcidin levels in patients with chronic hepatitis C

Girelli, D., Pasino, M., Goodnough, J. B., Nemeth, E., Guido, M., Castagna, A., Busti, F., Campostrini, N., Martinelli, N., Vantini, I., et al. (2009) · Journal of Hepatology

Iron Metabolism and DisordersHepatitis C virus research

Cited by 169

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Voight, B. F., Peloso, G. M., Orho-Melander, M., Frikke-Schmidt, R., Barbalic, M., Jensen, M. K., Hindy, G., Hólm, H., Ding, E. L., Johnson, T., et al. (2012) · The Lancet

Genetic Associations and EpidemiologyLipoproteins and Cardiovascular Health

Cited by 148

Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo

Poli, M., Girelli, D., Campostrini, N., Maccarinelli, F., Finazzi, D., Luscieti, S., Nai, A., & Arosio, P. (2011) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 148

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

Olivieri, O., Bassi, A., Stranieri, C., Trabetti, E., Martinelli, N., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., & Corrocher, R. (2003) · Journal of Lipid Research

Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 139

TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals

Nai, A., Pagani, A., Silvestri, L., Campostrini, N., Corbella, M., Girelli, D., Traglia, M., Toniolo, D., & Camaschella, C. (2011) · Blood

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 113

Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations

Traglia, M., Girelli, D., Biino, G., Campostrini, N., Corbella, M., Sala, C., Masciullo, C., Viganò, F., Buetti, I., Pistis, G., et al. (2011) · Journal of Medical Genetics

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 97

Analysis of Ferritins in Lymphoblastoid Cell Lines and in the Lens of Subjects With Hereditary Hyperferritinemia-Cataract Syndrome

Levi, S., Girelli, D., Perrone, F., Pasti, M., Beaumont, C., Corrocher, R., Albertini, A., & Arosio, P. (1998) · Blood

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 96

Low selenium status in the elderly influences thyroid hormones

Olivieri, O., Girelli, D., Azzini, M., Stanzial, A. M., Russo, C., Ferroni, M., & Corrocher, R. (1995) · Clinical Science

Selenium in Biological SystemsThyroid Disorders and Treatments

Cited by 95

ApoC-III gene polymorphisms and risk of coronary artery disease

Olivieri, O., Stranieri, C., Bassi, A., Zaia, B., Girelli, D., Pizzolo, F., Trabetti, E., Cheng, S., Grow, M. A., Pignatti, P. F., et al. (2002) · Journal of Lipid Research

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 70

Gain‐of‐function mutations in PIEZO1 directly impair hepatic iron metabolism via the inhibition of the BMP/SMADs pathway

Andolfo, I., Rosato, B. E., Manna, F., De Rosa, G., Marra, R., Gambale, A., Girelli, D., Russo, R., & Iolascon, A. (2020) · American Journal of Hematology

Iron Metabolism and DisordersErythrocyte Function and Pathophysiology

Cited by 61

Serum Hepcidin in Inflammatory Bowel Diseases: Biological and Clinical Significance

Bergamaschi, G., Di Sabatino, A., Albertini, R., Costanzo, F., Guerci, M., Masotti, M., Pasini, A., Massari, A., Campostrini, N., Corbella, M., et al. (2013) · Inflammatory Bowel Diseases

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 56

Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and “insulin-resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction

Olivieri, O., Martinelli, N., Sandri, M., Bassi, A., Guarini, P., Trabetti, E., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., et al. (2005) · Clinical Chemistry

Fatty Acid Research and HealthLipid metabolism and disorders

Cited by 50

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population

Lim, E. T., Würtz, P., Havulinna, A. S., Palta, P., Tukiainen, T., Rehnström, K., Esko, T., Mägi, R., Inouye, M., Lappalainen, T., et al. (2014) · PLoS Genetics

Genetic Associations and EpidemiologyGenomics and Rare Diseases

Cited by 49